Fundraising Fox
Hera BioLabs
1 known investors
Find your way into Hera BioLabs
17 people in our graph share verified history with the Hera BioLabs team — schools, employers, funds. One of them is your warm intro.
John T Maxwellunlockedknows Michael Schlosser, Ph.D. · together at WIL Research (overlapped)
knows the team · via Hera BioLabs
knows the team · via WIL Research
×7knows the team · via Jefferson Health
×2knows the team · via Chicago Innovation
Hera BioLabs provides gene editing technologies and cell line development services for drug discovery researchers. The company offers custom cell line platforms, animal models, and bioprocessing solutions using transposase technology and proprietary tools like the SRG Rat platform and CleanCut GS CHO system.
Founders & leadership
MS
Michael Schlosser, Ph.D.Chief Executive OfficerMichael Schlosser holds a Ph.D. and brings two decades of experience in pharmaceutical R&D strategy, business operations, and drug discovery across small molecules, proteins, and oligonucleotides in both pharmaceutical and contract research settings. He is CEO of Hera BioLabs, which provides gene editing technologies and cell line development services for drug discovery researchers.
Investors · 1
Frequently asked questions
- What does Hera BioLabs do?
- Hera BioLabs provides gene editing technologies and cell line development services for drug discovery researchers. The company offers custom cell line platforms, animal models, and bioprocessing solutions using transposase technology and proprietary tools like the SRG Rat platform and CleanCut GS CHO system.
- Who are Hera BioLabs's investors?
- Hera BioLabs's investors include Bluegrass Angel Venture.